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Abstract: Milk proteins are a heterogeneous group of polymeric compounds that have a wide range of different 
molecular structures and properties. They occur as caseins, whey proteins, enzymes, minor proteins and nitrogen 
compounds. Caseins constitute about 80% of the total proteins of cow’s milk. β-casein is an important part of the 
caseins, which makes up about 37% of the total caseins. Within β-casein, there are a number of variants which are 
genetically determined. However, there are thirteen genetic variants of β-casein found in cow´s milk. A1 and A2 
are the most common variants, which are called A1 β-casein (A1-milk) and A2 β-casein (A2-milk). The only 
difference between A1- and A2-milk is a difference in the 67th amino acid in the chain. At this position, A2-milk 
has a proline amino acid, while A1-milk has histidine amino acid. Several studies have reported that cow’s milk 
with a dominant or singular A2-milk may be healthier than A1-milk. These studies are based on digestion of A1-
milk which lead to release β-casomorphin-7 (BCM-7). Subsequently increase inflammation, Type-1-diabetes, 
heart disease, autism, gastrointestinal discomfort and other disease in the consumer. For this reason, there is a 
growing global interest in A2-milk. In conclusion, the effects of A1-milk compared to A2-milk on human health 
show mixed results. On the basis of the available results, we cannot conclusively assess the health effects of A1-
milk and A2-milk. Therefore, further investigations are needed.  
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1. Introduction 
 
Every day, billions of people around the world consume milk and milk products, which play a key role in 
healthy human nutrition and development throughout life. However, the role of milk and dairy products in human 
nutrition has been increasingly discussed in recent years [1, 2]. Milk is a complex food containing numerous 
nutrients (Tab. 1) and it makes a significant contribution to meeting the body’s needs for fat, proteins, sugar, 
minerals and vitamins. On the other hand, milk does not contain enough iron and folate to meet the needs of 
growing infants, and the low iron content is one reason that animal milk is not recommended for infants younger 
than 12 months. 
 
Tab. 1. Average composition of different milk lactating animals [3-6]. 
Lactating 
animals 
Dry Matter 
% 
Lactose 
% 
Protein 
% 
Fat 
% 
Ash 
% 
Cow 13 4.9 3.4 4.0 0.7 
Goat 13.2 4.1 3.4 3,5 0.8 
Sheep 19.3 4.8 5.5 7.4 0.9 
Buffalo 17.2 4.8 4.2 7.6 0.8 
Camel 10.6 4.0 2.3 3.5 0.7 
 
Currently, dairy cows are the main source of milk production in the world. However, milk from a range of other 
animal species is also consumed. Most of the constituents in milk do not work in isolation, but rather interact with 
other constituents. Often, they are involved in more than one biological process, sometimes with conflicting health 
effects. Thus, it’s possible that there is a connection between high dairy consumption and some diseases such as 
cardiovascular disease, Type-1-diabetes, Gastrointestinal disease, Autism, prostate cancer and other diseases [2, 7, 
8]. There are also reports suggesting that peptides in the milk may have a negative effect on human health [9]. For 
example, when digesting milk with a bad β-casein variant, BCM-7 is released [10], which may be responsible for 
milk protein intolerances. It has also shown that BCM-7 can be found in raw cow’s milk [11]. The presence of 
BCM-7 in raw cow’s milk is probably related to the increase of somatic cell counts (SCC) in milk [9]. SCC in 
milk are a normal phenomenon and their count increases dramatically during subclinical or clinical mastitis. 
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Increasing SCC is associated with increasing proteolysis of caseins. Therefore, the proteolytic activity in animals 
having a high SCC may contribute to the release of BCM-7. In the following, β-Casein variants, properties, 
structure, occurring in dairy cows and their influence on human health are presented and discussed. 
 
2. What is A1-and A2-milk? 
 
Milk proteins are a heterogeneous group of polymeric compounds that have a wide range of different molecular 
structures and properties. They occur as Caseins, whey proteins, proteins of the fat globule membrane, enzymes, 
minor proteins and nitrogen compounds [3, 12, 13] (Tab. 2). 
 
Tab. 2. Compositional protein quality in cow’s milk according to Barth and Behnke [14] with some changes. 
Protein components Protein subclasses Concentrations (g/kg) 
Caseins αs1-casein (A, B, C, D, E) 
αs2-casein (A, B, C, D) 
β-casein (A1, A2, A3, B, C, D, E, F, G, H1, H2, I).  
k-casein (A, B) 
γ-Casein 
10.3 
2.7 
9.6 
3.5 
0.8 
Whey proteins α-Lactalbumin (A, B, C) 
β-Lactoglobulin (A, B, C, D, E, F, G) 
Serum albumin 
Immunoglobulins (A, G1, G2, M, E) 
Lactoferrin 
Transferrin 
Other minor proteins  
1.2 
3.4 
0.4 
0.7 
0.1 
0.1 
0.1 
Enzymes Lysozyme, lactoperoxidase, and 60 others traces 
Peptide hormone Prolactin, growth hormone, insulin growth factor (IGF) traces 
Non-protein-nitrogen Urea, creatine, creatinine, peptide, uric acid, hippuric, orotic 
acid, free amino acids, nucleic acids.  
1.1 
 
It is known that casein represents about 80% of total protein in cow’s milk [3, 15]. Beta-casein is a second 
important part of casein, which constitutes up to 45% of bovine casein [16]. Within β-casein, there are a number 
of variants which are genetically determined [17]. The first evidence of genetic polymorphism in β-casein came 
from Aschaffenburg [18] while studying milk from Jersey and Guernsey cows. It was reported that β-casein existed 
as three polymorphs A, B and C. Subsequently, it was discovered that β-casein A could be separated into three 
additional variants [19]. It is known as β-casein A1, A2 and A3. After that, Eigel et al., [20] described seven genetic 
variants of β-casein (A1, A2, A3, B, C, D and E). The studies by Farrell et al., [17] and Kaminski et al., [12] have 
shown that, there are twelve genetic variants of β-casein found in cow’s milk (A1, A2, A3, B, C, D, E, F, G, H1, H2 
and I). Clemens [21] reported that there are thirteen genetic variants of β-casein in dairy cattle. But, A1, A2 and B 
milk are the most common forms among dairy cattle [7, 22]. Therefore, it is also called A1-milk and A2-milk. A1-
milk has been implicated in the literature in relation to human disease as a potential etiological factor in type-1-
diabetes mellitus, ischemic heart disease, schizophrenia, and autism [10]. Another variant of A2-milk has not been 
implicated in these diseases [23]. 
 
3. Biochemical structure of A1 β-casein and A2 β-casein  
 
Beta-casein is a 209 chain amino acid protein, and the A1 version has one amino acid that is different from A2 
[24, 25]. A1 has a histidine at position 67 that allows an enzymatic cleavage to occur releasing a 7 amino acid 
called BCM-7 [7, 10, 26]. The A2 variant has a proline at position 67 so that BCM-7 is not released [25] (Fig. 1). 
 
4. Cow breeds and type of milk 
 
As we know, the casein proteins make up about 80% of milk protein and one of these is β-casein, of which the 
two most common forms are A1 and A2. Originally, all milk was A2, but due to a genetic mutation at some point, 
the A1 form appeared [27]. That means the genetic mutation changed the amino acids from proline to histidine 
based and gradually became the prevalent form of beta casein. The modern dairy breeds still produce some A2-
milk although the percentage varies between breeds. The frequency of the A2 allele appears to be around 60% in 
Holsteins. This means that about 35% of Holstein Friesian produce A2-milk, 48% produce a mix of A1-and A2-
milk, and 16% produce A1-milk [28]. Therefore, Holstein Friesian has the lowest proportion of A2-milk in relation 
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to other breeds. Brown Swiss and Fleckvieh have the proportion at around 65%, which produce A2-milk [7, 29]. 
The Guernsey has the highest proportion of the A2-milk gene at over 90% [28]. All the other main dairy breeds 
have about 50%. Thus, most cows produce a combination of these two proteins A1-and A2-milk [12]. However, 
A1-milk is absent in purebred Asian and African cattle [25]. Similarly, the presence of A1-milk in other 
mammalian species is either absent or extremely rare [24, 30]. The avoidance of A1-milk is feasible within dairy-
based diets through the consumption of sheep, buffalo and goat milk or through the consumption of bovine milk 
from the native Asian and African bovine breeds [25]. However, the consumption of milk from European-type 
cattle is possible, which is free of the A1-milk. Such herds are being developed in many countries [7]. 
 
 
Figure .1. A1 and A2 Beta-Casein 
 
5. Which diseases can occur after consumption of cow’s milk with A1 or A2? 
 
The controversy surrounding A1 versus A2 relates to the digestion of β-casein. When proteins are digested, 
bioactive peptides can be released [31]. A peptide is simply a small chain of amino acids. This peptide called 
BCM-7 is a seven amino acid peptide that is thought to be much more commonly released when A1-milk is 
digested than when A2-milk is digested [9, 32-34]. BCM-7 has opioid-like properties that are suggested to affect 
up to 25% of the human population [26, 28, 34]. A few research groups suggest that BCM-7 may be linked to 
type-1-diabetes, heart disease, infant death, autism, and digestive problems [35-38]. While BCM-7 may affect the 
digestive system, it’s still unclear to what extent BCM-7 is absorbed intact into blood [8]. Studies have shown that 
BCM-7 is not found in the blood of healthy adults who drank cow’s milk, but a few tests indicate that BCM-7 may 
be present in infants [37-39]. Furthermore, Kost et al., [37] found that breast feeding has an advantage over 
artificial feeding for infants’ development during the first year of life and supports the hypothesis for deterioration 
of bovine casomorphin elimination as a risk factor for delay in psychomotor development and other diseases such 
as autism. Therefore, the world health organization (WHO) recommends that infants should be exclusively breast 
fed for six months and breastfeeding should continue beyond the second year to ensure healthy growth and 
development [40].  
    
5.1 Type-1-diabetes 
Type-1-diabetes is a form of diabetes mellitus. It is due to a lack of insulin due to the destruction of insulin-
producing β-cells in the islets of Langerhans of the pancreas by autoimmune processes. The contribution of cow’s 
milk containing A1-milk variant to the development of type-1-diabetes has been controversial for decades [41]. 
Cow’s milk, one of the first foods introduced early to infants, is one such putative environmental factor [42]. 
Children who have specific human leukocyte antigen genotype (HLA-DR) paired with a greater dietary intake of 
cow’s milk protein may be at an increased risk of developing islet autoimmunity and progression to Type-1-
diabetes [43]. However, Birgisdottir et al., [36] reported that lower consumption of A1-milk might be related to 
the lower incidence of type-1-diabetes in Iceland than in Scandinavia. But it was indicated that consumption in 
young childhood might be of more importance for the development of the disease incidence than consumption in 
adolescence. Similarly, McLachlan, [35] found that A1-milk consumption correlates strongly with type-1-diabetes 
incidence in 0-14-year-olds. Elliott et al. [26] indicated that total protein consumption did not strongly correlate 
with diabetes incidence (r=+0.402), but consumption of the A1-milk variant did (r=+0.726). Even more 
pronounced was the relation between β-casein (A1+B) consumption and diabetes (r=+982). Most compelling is 
the data analysis by Laugesen and Elliott [44] which demonstrated a positive correlation (r=0.92) between cow’s 
A1-milk supply per-capita and type-1-diabetes in 19 developed countries. This study clearly showed that a higher 
incidence rate was observed in Finland and Sweden (highest A1-milk consumption/per capita) and low rates have 
been found in Venezuela and Japan (lowest A1-milk consumption/per capita). In general, many studies have shown 
that consumption of A1-milk in childhood increased the risk of type-1-diabetes [10, 21, 26, 35, 36, 44] and in 
lactose intolerant individuals, lactose malabsorption and digestive comfort with lactose-containing milks was 
improved with milk containing exclusively A2-milk [45]. 
In addition, studies on animals have shown that no difference between A1-and A2-milk can be detected referring 
to type-1-diabetes [26, 46-48]. On the contrary, the consumption of A1-milk in genetically susceptible mice 
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increases the incidence of type-1-diabetes, which only becomes evident in later generations [41]. 
 
5.2 Heart disease 
Previous studies indicated a correlation between the consumption of the milk protein A1-milk (excluding milk 
protein in cheese) and ischemic heart disease mortality in West Germany, Toulouse in France and Belfast in 
Northern Ireland and the value was a r2= 0.86 [35]. Similar results have indicated that A1 β-casein per capita 
supply in milk and cream was significantly and positively correlated with ischaemic heart disease in 20 countries 
[44, 49]. On the contrary, the studies in fifteen asymptomatic participants (six male; nine female) at high risk of 
developing cardiovascular disease have shown that the supplementation with A1-milk has not any cardiovascular 
health disadvantage over consumption of A2-milk [50]. In the same way, the studies by Venn et al., [49] showed 
no evidence that dairy products containing beta-casein A1 or A2 exerted differential effects on plasma cholesterol 
concentration in humans. 
  
5.3 Gastrointestinal disease 
There are a number of studies on the impact of A1- or A2-milk on digestive tract health [51, 52]. However, the 
increasing consumption of dairy products is associated with an increase in the risk of gastrointestinal function [53 
-56]. Ho et al., [51] have found that A1-milk led to significantly higher stool consistency values (Bristol Stool 
Scale) compared with the A2-milk. Furthermore the authors found a significant positive association between 
abdominal pain and stool consistency on the A1-milk diet (r=0.52), but not the A2-milk diet (r=-0.13). Jianqin et 
al., [57] reported that the consumption of milk containing both types (A1-milk and A2-milk) was associated with 
significantly greater post-dairy digestive discomfort symptoms; higher concentrations of inflammation-related 
biomarkers and BCM-7; longer gastrointestinal transit times and lower levels of short-chain fatty acids. On the 
other hand, consumption of milk containing only A2-milk did not aggravate post-dairy digestive discomfort 
symptoms. Other studies in Germany have shown that after the application of A2-milk in 10 people who cannot 
tolerate A1-milk, have not had gastrointestinal problems [7]. He et al. [52] investigated that milk containing A2-
milk attenuated acute gastrointestinal symptoms of milk intolerance, while conventional milk containing A1-milk 
reduced lactase activity and increased gastrointestinal symptoms.         
Animal studies have shown that the effect of A1- versus A2-milk on gastrointestinal was directly influenced 
[56, 58]. Similarly, it has been reported that casein and its derivatives, particularly BCM-7, exert a variety of 
effects on gastrointestinal function in animals, including reducing the frequency and amplitude of intestinal 
contractions [53, 59-61]. Interestingly, Barnett et al., [56] also shown in rats that A1-milk feeding relative to A2-
milk feeding significantly increased the colonic activity of the inflammatory marker myeloperoxidase by 65%, an 
effect also negated by the opioid blocker naloxone.    
In general, it has been shown that the consumption of milk containing A1-milk would lead to systemic 
inflammation and gastrointestinal motility through the release of BCM-7 [51, 57]. In fact, further animal research 
and clinical trials is needed to compare disease risks of A1-free versus ordinary milk. 
 
5.4 Autism 
Autism, also called autism spectrum disorder, is a group of neurodevelopmental conditions characterized by 
social deficit and repetitive behaviors. It is believed that peptides like BCM-7 might play a role in the development 
of autism. However, the studies on this relationship are not always displayed [62-64]. Kost et al. [37] have shown 
that breast feeding has an advantage over artificial feeding for infant’s development during the first months of life 
and support the hypothesis for deterioration of bovine casomorphin elimination as a risk factor for delay in 
psychomotor development and other diseases such as autism. On the other hand, some authors have suggested that 
food peptides might be able to determine toxic effects at the level of the central nervous system by interacting with 
neurotransmitters. In fact a worsening of neurological symptoms has been reported in autistic patients after the 
consumption of milk and wheat [65]. That means that there was a close relationship between food allergy and 
infantile autism. In conclusion, it can be said that A1-milk has no significant effect on autism symptom compared 
to A2-milk and further investigations are necessary. 
    
5.5 Sudden death of infants 
Sudden infant death syndrome is the most common cause of death in infants under 12 months old and its 
pathogenesis is complex and multifactorial. Casein-derived peptides as BCM-7 have been suggested to play a role 
in sudden infant death syndrome. Sun et al. [66] described in a study the possible relationship between BCM-7 
and sudden infant death syndrome. On the other hand, the studies by Wasilewska et al., [38] have shown that the 
sera of some infants after an apnoea event contained more BCM-7 than that of the healthy infants in the same age. 
These results indicate that some children may be sensitive to A1-milk. But more research is needed to get concrete 
results before any firm conclusions can be reached. 
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6. Conclusion 
 
Whether A2-milk is really healthier than A1-milk or not; farmers, breeders, societies and the media have been 
dealing with this for several years. The difference between the two milk variants is only a single amino acid 
deviation of beta casein. In the course of development, the A1-milk mutation has occurred at some point, because 
the A2-milk is considered the more natural form. A1-milk and the peptide BCM-7 may be linked to heart disease, 
diabetes, autism, sudden death of infants and inflammation in the digestive system. The results are mixed and 
further studies are needed.  
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